Another explanation is that SLE patients have poor control of PRL secretion, as evidenced by high cyclo (His-pro), which is a PRL secretion inhibitor, and low homovanillic acid (a dopamine metabolite) [49]. The gene discussed is PRL; the disease is systemic lupus erythematosus.